Lower Gastrointestinal Bleeding Imaging
- Author: Marc D Haber, MD; Chief Editor: Kyung J Cho, MD, FACR, FSIR more...
Lower gastrointestinal (GI) hemorrhage is defined as bleeding from the bowel distal to the ligament of Treitz (see the following image). Lower GI bleeding can be of an acute or chronic nature. Massive gastrointestinal bleeding will result in hemodynamic instability and decreasing hemoglobin levels, which need to be treated with transfusions.
Diverticulosis has been implicated as the source of bleeding in as many as 60% of cases of lower GI bleeding. The diverticula are more prevalent in the left or sigmoid colon, but positive arteriographic findings for bleeding localizes the bleeding to the right colon in 60% of cases.
Colonoscopy after rapid oral purging has emerged as the procedure of choice for the evaluation of acute lower GI bleeding (69-90% yield), and it also provides a means for therapy. This procedure involves the use of thermal contact modalities or epinephrine injections in cases of diverticula and vascular ectasia. Similarly, other causes of lower GI bleeding can be effectively treated during colonoscopy.
However, the 2 widely used diagnostic tests for lower GI bleeding are nuclear scanning (see the image above) during episodes of bleeding or angiography (see the images below).[2, 3] In cases in which colonoscopy is unsuccessful, scanning during episodes of bleeding and angiography are considered to be next imaging tests to determine the cause of the bleeding. Catheter directed angiography remains the best option in a patient in unstable condition and should be performed in cases of massive bleeding.
An advantage of catheter directed angiography over colonoscopy or scintigraphy is that no special preparation is needed. Thus, it can be performed in a relatively short period; angiography also provides a means for immediate treatment. However, patients in stable condition can undergo scintigraphy to guide and increase the yield of angiography.
Scintigraphy and/or angiography also play important roles in diagnosis and embolization when colonoscopy reveals negative findings or when it is not feasible. Some investigators also advocate an upper GI endoscopy after colonoscopy yields negative results, as about 10% of cases are ultimately found to involve an upper GI source of bleeding.
Computed tomography angiography (CTA) is increasingly becoming an accepted alternative to catheter-directed angiography and may ultimately become the favored alternative in patients with suspected GI bleeding.
Two transcatheter methods for the treatment of GI bleeding include vasopressin infusion and embolization. Superselective embolization has become more accepted in recent years.[7, 8, 9, 10]
Vasopressin infusion causes vasoconstriction of the small arteries, arterioles, and capillaries, and it has been used for both upper and lower GI bleeds. The rate of successful control of bleeding has been reported to be 70-90%. The repeat bleeding rate is reported to be 17-27%.
The infusion is started with the catheter in the main trunk of the mesenteric artery that is the cause of bleeding. The initial rate is 0.2 U/min. A follow-up angiogram is obtained after about 30 minutes. In cases of active hemorrhage, the rate is increased to 0.4 U/min. Higher rates are not recommended because the potential complications from vasoconstriction can exceed the benefits. The infusion is tapered at 6- to 12-hour intervals and then stopped if no further bleeding ensues.
Complications of vasopressin infusion include myocardial ischemia, arrhythmia, hypertension, bowel ischemia, peripheral vascular ischemia, and antidiuretic effects. Because of significant rebleeding, variable success, the need for ICU monitoring, and the aforementioned adverse effects of the infusion, renewed interest in embolization therapy has developed over the last few years. In fact, embolization has now become the preferred transcatheter therapy. Embolization also achieves immediate control of the bleeding, and ICU monitoring to the degree required with vasopressin infusion is avoided.
The aim of embolization is to decrease the arterial inflow so that the pressure at the bleeding site is decreased and hemostasis occurs. The important issue is to avoid devascularization of the tissues, which leads to ischemia and infarction.
In 1974, Bookstein first described transcatheter embolization by using an autologous clot. Since then, various investigators have described small series of transcatheter embolization for lower GI bleeds, with varying success. The potential complication of bowel ischemia and infarction initially limited use of this technique. Earlier groups had described postembolization bowel infarction rates ranging from 0% to 23%. However, some authors claim that the high rate of significant ischemia may have been related to proximal embolization sites in relation to the marginal artery, as lack of large vascular collaterals in the large bowel may jeopardize significant areas of colon.
With this issue in mind, further studies with superselective catheterization techniques and embolization were performed using polyvinyl alcohol (PVA) particles and Gelfoam, although most of the studies have used microcoils (platinum coils), either alone or in conjunction with Gelfoam or PVA.
A study by Evangelista and Hallisey supported the use of superselective embolization as the most effective procedure in reducing complication rates. The investigators reported an 88% success rate and argued against the use of PVA as the sole embolization agent, as the small particles may reach intramural circulation and thus occlude the submucosal plexus beyond the level of collateralization, leading to significant bowel ischemia. An advantage of coils is that they are visible and, therefore, more controllable.
Bandi et al also supported superselective embolization as a feasible, safe, and effective technique for treating acute lower GI hemorrhage. They performed embolization in only those patients in whom they could successfully catheterize the arteria recta leading to the bleeding point. PVA alone (150-500 µm) was used in 28 of these procedures. In 25 patients who underwent objective follow-up with colonoscopy (n = 12), surgery (n = 9), or both (n = 4), mucosal ischemia was demonstrated in 6 (24%) of these patients, but they remained asymptomatic without clinical sequela. No clinically significant bowel ischemia was seen.
New advances are being made with computed tomographic angiography (CTA) and magnetic resonance angiography (MRA). Junquera et al used CTA to evaluate suspected colonic angiodysplasia. The sensitivity of CTA in the detection of colonic angiodysplasia was 70%, its specificity was 100%, and it had 100% positive predictive values, compared with findings of angiography or colonoscopy.
A recent meta-analysis of 672 patients from 22 studies demonstrated a sensitivity of 85.2% and a specificity of 92.1% for CT angiography in detecting active acute GI hemorrhage.
Magnetic Resonance Imaging
In an animal study, Hilfiker et al evaluated use of 3-dimensional (3-D) MRI. The investigators compared technetium-99m (99m Tc)-labeled red blood cell (RBC) scintigraphy with 3-D MRI after the intravascular administration of contrast agent. MRI had 100% sensitivity and specificity, compared with 78% sensitivity and 72% specificity for scintigraphy.
Scintigraphic bleeding scans are performed by intravenously injecting radiotracers (e.g. red blood cells, sulfur colloid) tagged with radioisotopes (eg, technetium-99m) and acquiring images for usually between 60 and 90 minutes. If the findings are positive, 2-D planar images will demonstrate a focus of radiotracer in an abnormal location, which, over time, will change in position because of bowel peristalsis.
The main advantage of this examination is its ability to detect bleeding rates as low as 0.05-0.1 mL/min, as compared to 0.5-1.0 mL/min with angiography. It is highly sensitive and specific, with reported rates of 93% and 95%, respectively. Additionally, it is noninvasive, and no special patient preparation is required.[18, 19]
As with other radiologic examinations, its disadvantages are that detection is dependent on active bleeding. Furthermore, there is a controversy regarding the accuracy of scintigraphic scans at localizing sites of bleeding. One group reported inaccurate localization leading to a surgical error rate of 42%. However, some authors claim that most of the available reports in the literature base their conclusions on results obtained with older techniques. The newer techniques involve greater dynamic imaging (frequent acquisition of data), extra-large field-of-view gamma cameras, and cine scintigraphy or movie-mode displays. Later studies have shown that RBC scans have an accuracy of nearly 90% in the localization of the bleeding site.
Examples of scintigraphic agents include technetium-99m-labeled RBCs and, less commonly,99m Tc sulfur colloid.[20, 21, 22, 23, 24] Although both agents have similar bleeding detection rates, ] m Tc RBC scanning is felt to be superior to m Tc sulfur colloid for the following reasons[ :
99m Tc-labeled RBCs persist longer in the intravascular compartment. improving bleeding site localization
Repeat imaging can be performed with 99m Tc RBC scanning after an interval of as long as 24 hours
99m Tc sulfur colloid scans may potentially mask bleeding in the upper abdomen due to activity in the liver and spleen
99m Tc sulfur colloid scans deliver a larger absorbed dose to organs in the upper abdomen
The following is an example of a99m Tc RBC scan:
Degree of confidence
Scintigraphic bleeding scans are highly sensitive and specific at detecting the presence of active gastrointestinal bleeding, with reported rates of 93% and 95%, respectively. For this reason, scintigraphic bleeding scans are commonly used as preliminary examinations prior to angiography.
As scintigraphic bleeding scans detect lower rates of bleeding, if a scintigraphic scan is negative, an invasive angiographic procedure may potentially be avoided. If the preliminary scan is positive, then studies have shown improved angiographic bleeding detection following positive scintigraphic scans. This was illustrated by Gunderman et al, who described that, without scintigraphic screening, angiograms depicted bleeding at a rate of 22%, which increased to 53% after scintigraphic screening.
The earliest description of the angiographic demonstration of GI bleeding was in 1963. Since then, angiography has been used in the evaluation of GI bleeding, although with varying frequency over time and with the advent of colonoscopy and scintigraphy.[27, 28, 29, 30, 31, 32]
Screen-film arteriography can demonstrate bleeding at rates as low as 0.5 mL/min in dogs, although some authors claim that the actual detectable rate of bleeding in clinical conditions may be in the range of 1.0-1.5 mL/min. Digital subtraction angiography (DSA) has been reported to be more sensitive than conventional screen-film angiography. In 1988, Rees et al showed that DSA tended to be more sensitive than conventional angiography in depicted simulated extravasation in vitro; however, in the clinical study, DSA was severely limited in evaluation of the lower GI tract because of misregistration artifact caused by bowel motion. In another study, Kruger et al showed similar findings. The investigators reported that DSA was superior to conventional angiography, provided that it is performed with adequate parasympathicolysis and suspended respiration.
On angiograms, hemorrhage is identified as the extravasation of contrast material into the lumen of the bowel (see the following images). The contrast material extravasation can be free or pooling, and it persists during or even after the injection. The angiodysplasia has been described to have a characteristic appearance. It appears as a vascular tuft, along with an early and persistent draining vein.
Degree of confidence
The clinical sensitivity of angiography has been reported variably in different studies. The typical values are around 60%. Attempts to identify predictors for positive angiographic findings have shown mixed results. In a retrospective study, Pennoyer et al did not identify any single useful predictor to increase the likelihood of obtaining a positive angiographic result. Evaluated factors included a history of previous GI bleeding, transfusions, orthostatic hypotension, and tachycardia. However, Nicholson et al found a perfect correlation between a systolic blood pressure of less than 100 mm Hg and a positive arteriographic result. Therefore, some clinicians advocate immediate arteriography rather than nuclear medicine imaging in hemodynamically unstable patients.
Pharmacologic techniques have been used to increase the diagnostic yield of arteriography. These include the use of heparin, vasodilators, and thrombolytics. The reported studies show a 33-65% increase in the yield of angiography. These small studies have not shown any significant complications, although larger studies are needed to prove safety of this method.
A Scottish Intercollegiate Guidelines Network (SIGN). Management of acute upper and lower gastrointestinal bleeding. A national clinical guideline. Edinburgh, Scotland: SIGN publication; 105:
Artigas JM, Martí M, Soto JA, Esteban H, Pinilla I, Guillén E. Multidetector CT Angiography for Acute Gastrointestinal Bleeding: Technique and Findings. Radiographics. 2013 Sep. 33(5):1453-70. [Medline].
Allen TW, Tulchinsky M. Nuclear medicine tests for acute gastrointestinal conditions. Semin Nucl Med. 2013 Mar. 43(2):88-101. [Medline].
Saruta M, Papadakis KA. Capsule endoscopy in the evaluation and management of inflammatory bowel disease: a future perspective. Expert Rev Mol Diagn. 2009 Jan. 9(1):31-6. [Medline].
Sabharwal R, Vladica P, Chou R, Law WP. Helical CT in the diagnosis of acute lower gastrointestinal haemorrhage. Eur J Radiol. 2006 May. 58(2):273-9. [Medline].
Bandi R, Shetty PC, Sharma RP, et al. Superselective arterial embolization for the treatment of lower gastrointestinal hemorrhage. J Vasc Interv Radiol. 2001 Dec. 12(12):1399-405. [Medline].
Funaki B, Kostelic JK, Lorenz J, et al. Superselective microcoil embolization of colonic hemorrhage. AJR Am J Roentgenol. 2001 Oct. 177(4):829-36. [Medline].
Guy GE, Shetty PC, Sharma RP, et al. Acute lower gastrointestinal hemorrhage: treatment by superselective embolization with polyvinyl alcohol particles. AJR Am J Roentgenol. 1992 Sep. 159(3):521-6. [Medline].
Ledermann HP, Schoch E, Jost R, et al. Superselective coil embolization in acute gastrointestinal hemorrhage: personal experience in 10 patients and review of the literature. J Vasc Interv Radiol. 1998 Sep-Oct. 9(5):753-60. [Medline].
Uflacker R. Transcatheter embolization for treatment of acute lower gastrointestinal bleeding. Acta Radiol. 1987 Jul-Aug. 28(4):425-30. [Medline].
Bookstein JJ, Chlosta EM, Foley D, Walter JF. Transcatheter hemostasis of gastrointestinal bleeding using modified autogenous clot. Radiology. 1974 Nov. 113(2):277-85. [Medline].
Evangelista PT, Hallisey MJ. Transcatheter embolization for acute lower gastrointestinal hemorrhage. J Vasc Interv Radiol. 2000 May. 11(5):601-6. [Medline].
Junquera F, Quiroga S, Saperas E, et al. Accuracy of helical computed tomographic angiography for the diagnosis of colonic angiodysplasia. Gastroenterology. 2000 Aug. 119(2):293-9. [Medline].
García-Blázquez V, Vicente-Bártulos A, Olavarria-Delgado A, Plana MN, van der Winden D, Zamora J. Accuracy of CT angiography in the diagnosis of acute gastrointestinal bleeding: systematic review and meta-analysis. Eur Radiol. 2013 May. 23(5):1181-90. [Medline].
Hilfiker PR, Weishaupt D, Kacl GM, et al. Comparison of three dimensional magnetic resonance imaging in conjunction with a blood pool contrast agent and nuclear scintigraphy for the detection of experimentally induced gastrointestinal bleeding. Gut. 1999 Oct. 45(4):581-7. [Medline].
Thorne DA, Datz FL, Remley K, Christian PE. Bleeding rates necessary for detecting acute gastrointestinal bleeding with technetium-99m-labeled red blood cells in an experimental model. J Nucl Med. 1987. 28(4):514-20.
Bunker SR, Lull RJ, Tanasescu DE, Redwine MD, Rigby J, Brown JM. Scintigraphy of gastrointestinal hemorrhage: superiority of 99mTc red blood cells over 99mTc sulfur colloid. AJR Am J Roentgenol. 1984 Sep. 143(3):543-8. [Medline].
Tulchinsky M. Lower gastrointestinal bleeding diagnosed by red blood cell scintigraphy in a patient with a left ventricular assist device. ClinNucl Med. 2008. 33(12):856-8.
Alavi A, Ring EJ. Localization of gastrointestinal bleeding: superiority of 99mTc sulfur colloid compared with angiography. AJR Am J Roentgenol. 1981 Oct. 137(4):741-8. [Medline].
Smith R, Copely DJ, Bolen FH. 99mTc RBC scintigraphy: correlation of gastrointestinal bleeding rates with scintigraphic findings. AJR Am J Roentgenol. 1987 May. 148(5):869-74. [Medline].
Rantis PC Jr, Harford FJ, Wagner RH, Henkin RE. Technetium-labelled red blood cell scintigraphy: is it useful in acute lower gastrointestinal bleeding?. Int J Colorectal Dis. 1995. 10(4):210-5. [Medline].
Voeller GR, Bunch G, Britt LG. Use of technetium-labeled red blood cell scintigraphy in the detection and management of gastrointestinal hemorrhage. Surgery. 1991 Oct. 110(4):799-804. [Medline].
Wu Y, Seto H, Shimizu M, et al. Sequential subtraction scintigraphy with 99Tcm-RBC for the early detection of gastrointestinal bleeding and the calculation of bleeding rates: phantom and animal studies. Nucl Med Commun. 1997 Feb. 18(2):129-38. [Medline].
Dusold R, Burke K, Carpentier W, Dyck WP. The accuracy of technetium-99m-labeled red cell scintigraphy in localizing gastrointestinal bleeding. Am J Gastroenterol. 1994 Mar. 89(3):345-8. [Medline].
Gunderman R, Leef J, Ong K, Reba R, Metz C. Scintigraphic screening prior to visceral arteriography in acute lower gastrointestinal bleeding. J Nucl Med. 1998 Jun. 39(6):1081-3. [Medline].
Pennoyer WP, Vignati PV, Cohen JL. Mesenteric angiography for lower gastrointestinal hemorrhage: are there predictors for a positive study?. Dis Colon Rectum. 1997 Sep. 40(9):1014-8. [Medline].
Gomes AS, Lois JF, McCoy RD. Angiographic treatment of gastrointestinal hemorrhage: comparison of vasopressin infusion and embolization. AJR Am J Roentgenol. 1986 May. 146(5):1031-7. [Medline].
Rosch J, Keller FS, Wawrukiewicz AS, et al. Pharmacoangiography in the diagnosis of recurrent massive lower gastrointestinal bleeding. Radiology. 1982 Dec. 145(3):615-9. [Medline].
Bloomfeld RS, Smith TP, Schneider AM, Rockey DC. Provocative angiography in patients with gastrointestinal hemorrhage of obscure origin. Am J Gastroenterol. 2000 Oct. 95(10):2807-12. [Medline].
Hastings GS. Angiographic localization and transcatheter treatment of gastrointestinal bleeding. Radiographics. 2000 Jul-Aug. 20(4):1160-8. [Medline].
Koval G, Benner KG, Rosch J, Kozak BE. Aggressive angiographic diagnosis in acute lower gastrointestinal hemorrhage. Dig Dis Sci. 1987 Mar. 32(3):248-53. [Medline].
Rees CR, Palmaz JC, Alvarado R, et al. DSA in acute gastrointestinal hemorrhage: clinical and in vitro studies. Radiology. 1988 Nov. 169(2):499-503. [Medline].
Kruger K, Heindel W, Dolken W, et al. Angiographic detection of gastrointestinal bleeding. An experimental comparison of conventional screen-film angiography and digital subtraction angiography. Invest Radiol. 1996 Jul. 31(7):451-7. [Medline].
Karanicolas PJ, Colquhoun PH, Dahlke E, Guyatt GH. Mesenteric angiography for the localization and treatment of acute lower gastrointestinal bleeding. Can J Surg. 2008 Dec. 51(6):437-41. [Medline].
Nicholson ML, Neoptolemos JP, Sharp JF, et al. Localization of lower gastrointestinal bleeding using in vivo technetium-99m-labelled red blood cell scintigraphy. Br J Surg. 1989 Apr. 76(4):358-61. [Medline].
Alavi A, Dann RW, Baum S, Biery DN. Scintigraphic detection of acute gastrointestinal bleeding. Radiology. 1977 Sep. 124(3):753-6. [Medline].
Bunker SR, Lull RJ, Tanasescu DE, et al. Scintigraphy of gastrointestinal hemorrhage: superiority of 99mTc red blood cells over 99mTc sulfur colloid. AJR Am J Roentgenol. 1984 Sep. 143(3):543-8. [Medline].
Dusold R, Burke K, Carpentier W, Dyck WP. The accuracy of technetium-99m-labeled red cell scintigraphy in localizing gastrointestinal bleeding. Am J Gastroenterol. 1994 Mar. 89(3):345-8. [Medline].
Gerlock AJ Jr, Muhletaler CA, Berger JL, et al. Infarction after embolization of the ileocolic artery. Cardiovasc Intervent Radiol. 1981. 4(3):202-5. [Medline].
Gunderman R, Leef J, Ong K, et al. Scintigraphic screening prior to visceral arteriography in acute lower gastrointestinal bleeding. J Nucl Med. 1998 Jun. 39(6):1081-3. [Medline].
Holder LE. Radionuclide imaging in the evaluation of acute gastrointestinal bleeding. Radiographics. 2000 Jul-Aug. 20(4):1153-9. [Medline].
Hunter JM, Pezim ME. Limited value of technetium 99m-labeled red cell scintigraphy in localization of lower gastrointestinal bleeding. Am J Surg. 1990 May. 159(5):504-6. [Medline].
Lefkovitz Z, Cappell MS, Kaplan M, et al. Radiology in the diagnosis and therapy of gastrointestinal bleeding. Gastroenterol Clin North Am. 2000 Jun. 29(2):489-512. [Medline].
Ng DA, Opelka FG, Beck DE, et al. Predictive value of technetium Tc 99m-labeled red blood cell scintigraphy for positive angiogram in massive lower gastrointestinal hemorrhage. Dis Colon Rectum. 1997 Apr. 40(4):471-7. [Medline].
Orecchia PM, Hensley EK, McDonald PT, Lull RJ. Localization of lower gastrointestinal hemorrhage. Experience with red blood cells labeled in vitro with technetium Tc 99m. Arch Surg. 1985 May. 120(5):621-4. [Medline].
Peck DJ, McLoughlin RF, Hughson MN, Rankin RN. Percutaneous embolotherapy of lower gastrointestinal hemorrhage. J Vasc Interv Radiol. 1998 Sep-Oct. 9(5):747-51. [Medline].
Rosenkrantz H, Bookstein JJ, Rosen RJ, et al. Postembolic colonic infarction. Radiology. 1982 Jan. 142(1):47-51. [Medline].
Ryan JM, Key SM, Dumbleton SA, Smith TP. Nonlocalized lower gastrointestinal bleeding: provocative bleeding studies with intraarterial tPA, heparin, and tolazoline. J Vasc Interv Radiol. 2001 Nov. 12(11):1273-7. [Medline].
Thorne DA, Datz FL, Remley K, Christian PE. Bleeding rates necessary for detecting acute gastrointestinal bleeding with technetium-99m-labeled red blood cells in an experimental model. J Nucl Med. 1987 Apr. 28(4):514-20. [Medline].
Tulchinsky M. Lower gastrointestinal bleeding diagnosed by red blood cell scintigraphy in a patient with a left ventricular assist device. Clin Nucl Med. 2008 Dec. 33(12):856-8. [Medline].
Winzelberg GG, Froelich JW, McKusick KA, et al. Radionuclide localization of lower gastrointestinal hemorrhage. Radiology. 1981 May. 139(2):465-9. [Medline].
Zuckerman DA, Bocchini TP, Birnbaum EH. Massive hemorrhage in the lower gastrointestinal tract in adults: diagnostic imaging and intervention. AJR Am J Roentgenol. 1993 Oct. 161(4):703-11. [Medline].